MTB
63
-2
AXP
66
2
T
50
3
QCOM
48
-7
NAVI
41
-3
VRTX
46
2
USB
50
2
ABT
57
-5
DG
2
-6
UNH
61
6
APA
21
2
LUV
39
-5
TXT
48
2
PVH
52
-3
AA
51
3
ILMN
32
-3
ED
48
3
GRMN
62
-3
PX
75
5
IFF
53
2
MTB
63
-2
AXP
66
2
T
50
3
QCOM
48
-7
NAVI
41
-3
VRTX
46
2
USB
50
2
ABT
57
-5
DG
2
-6
UNH
61
6
APA
21
2
LUV
39
-5
TXT
48
2
PVH
52
-3
AA
51
3
ILMN
32
-3
ED
48
3
GRMN
62
-3
PX
75
5
IFF
53
2
Financhill
Back

Genmab AS Stock Predictions

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
17

GNMSF
Genmab AS

Last Price:
202.48
Seasonality Move:
-0.77%

7 Day Trial

ALL ACCESS PASS

$ 7

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Genmab AS Stock Forecast

  • Over the next 52 weeks, Genmab AS has on average historically risen by 8.1% based on the past 10 years of stock performance.
  • Genmab AS has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
  • Is Genmab AS Stock Undervalued?
    The current Genmab AS [GNMSF] share price is $202.48. The Score for GNMSF is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • GNMSF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Genmab AS Stock Go Up Next Year?

  • Over the next 52 weeks, Genmab AS has on average historically risen by 8.1% based on the past 10 years of stock performance.

Genmab AS Stock Rating

Sell
17
Genmab AS (GNMSF) is a Sell

Is Genmab AS overpriced?

  • Genmab AS has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Genmab AS Stock Price History

Is GNMSF stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GNMSF is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
OTCM
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
genmab.com

52-Week Data

52-Week High:
334.33
52-Week Low:
201.93

Prediction Charts

Market Cap:
12.86B
Price in USD:
202.48
Volume:
552
Beta:
0.65

Technical Analysis

SMA50:
233.37
SMA100:
249.81
SMA200:
267.15
52-Wk Change:
-38.27%

Stock Predictions

  • Is Genmab AS stock public?
    Yes, Genmab AS is a publicly traded company.
  • What is the Genmab AS stock quote today?
    The Genmab AS stock price is 202.48 USD today.
  • How to buy Genmab AS stock online?
    You can buy Genmab AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-1 229.98 220.72 229.98 220.72
Nov-4 229.34 226.00 229.34 218.70
Nov-5 220.28 220.28 229.07 218.81
Nov-6 216.80 225.80 225.80 213.80
Nov-7 226.63 231.17 231.17 220.42
Nov-8 233.34 223.79 236.40 221.10
Nov-11 232.36 230.00 237.00 223.30
Nov-12 224.03 231.93 233.27 220.95
Nov-13 215.68 215.68 224.62 212.70
Nov-14 224.35 220.50 224.35 209.50
Nov-15 205.21 212.71 216.85 202.30
Nov-18 201.93 210.76 211.84 201.93
Nov-19 201.90 201.18 208.40 201.18
Nov-20 200.96 202.48 209.92 200.96

Genmab AS Earnings

Genmab AS Earnings Report: Per Share Genmab AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Genmab AS Forecast Revenue Growth

Genmab AS Stock Analysis: Historical quarterly revenues per share for Genmab AS and historical quarterly revenue growth:

* Genmab AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.